Featured series 
Tag: Ragon Institute
-
Nation & World
COVID-19 vaccine protects mothers — and their newborns
Pregnant women show robust immune response to COVID vaccines, pass antibodies to newborns.
-
Nation & World
Harvard president reflects on past year, and looks ahead
Harvard President Larry Bacow reflects on how the Harvard community has met the challenges posed by COVID-19, and to look ahead how the University is tackling some of the world’s most pressing problems.
-
Nation & World
Antibody evolution may predict COVID-19 outcomes
For COVID-19, the difference between surviving and not surviving severe disease may be due to the quality, not the quantity, of the patients’ antibody development and response, suggests a new study.
-
Nation & World
Vaccines can protect against COVID-19 in nonhuman primates, study says
Harvard-affiliated Beth Israel Deaconess Medical Center has developed vaccines — currently being tested in animal models — that are designed to train the body’s immune system to recognize the virus swiftly upon exposure and respond quickly to disable it.
-
Nation & World
A shot in the arm for vaccine research
Immunology research at the Ragon Institute of MGH, MIT, and Harvard has advanced an HIV vaccine into the clinic, and will diversify thanks to a major gift from Phillip T. and Susan M. Ragon.
-
Nation & World
A promising strategy against HIV
Harvard Stem Cell Institute researchers at Massachusetts General and Boston Children’s hospitals for the first time have used a relatively new gene-editing technique to create what could prove to be an effective technique for blocking HIV from invading and destroying patients’ immune systems.
-
Nation & World
The melding of technology
Former MIT President Susan Hockfield discussed the power of technology’s ongoing convergence during a session at the John F. Kennedy Jr. Forum.
-
Nation & World
Discovering where HIV persists in spite of treatment
HIV antiviral therapy lets infected people live relatively healthy lives for many years, but the virus doesn’t go away completely. If treatment stops, the virus multiplies again from hidden reservoirs in the body. Researchers may have found HIV’s viral hiding place — in a small group of recently identified T cells with stem cell-like properties.
-
Nation & World
Ragon study is honored
A study by researchers at the Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard is among those chosen to receive Top 10 Clinical Research Achievement Awards from the Clinical Research Foundation.
-
Nation & World
Cells that kill HIV-infected cells
Harvard researchers find that a subpopulation of the immune cells targeted by HIV may play an important role in controlling viral loads after initial infection, potentially helping to determine how quickly infection will progress.
-
Nation & World
Kavanagh receives grant for HIV research
Daniel G. Kavanagh, a member of the faculty at the Ragon Institute, is one of the winners of the Bill & Melinda Gates Foundation’s Grand Challenges Explorations initiative.